| Product Code: ETC10536175 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Ankylosing Spondylitis Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Ankylosing Spondylitis Treatment Market - Industry Life Cycle |
3.4 Israel Ankylosing Spondylitis Treatment Market - Porter's Five Forces |
3.5 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume Share, By Treatment Stage, 2021 & 2031F |
3.7 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Ankylosing Spondylitis Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about ankylosing spondylitis among healthcare professionals and patients |
4.2.2 Technological advancements in treatment options such as biologics and targeted therapies |
4.2.3 Rising prevalence of ankylosing spondylitis in Israel due to changing lifestyle factors and genetic predisposition |
4.3 Market Restraints |
4.3.1 High cost of advanced treatment options such as biologics leading to limited access for some patients |
4.3.2 Stringent regulatory requirements for approval of new treatment options |
4.3.3 Limited availability of specialized healthcare professionals for ankylosing spondylitis management in Israel |
5 Israel Ankylosing Spondylitis Treatment Market Trends |
6 Israel Ankylosing Spondylitis Treatment Market, By Types |
6.1 Israel Ankylosing Spondylitis Treatment Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume, By TNF Inhibitors, 2021 - 2031F |
6.1.4 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume, By IL-17 Inhibitors, 2021 - 2031F |
6.1.5 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume, By NSAIDs, 2021 - 2031F |
6.1.6 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume, By Corticosteroids, 2021 - 2031F |
6.2 Israel Ankylosing Spondylitis Treatment Market, By Treatment Stage |
6.2.1 Overview and Analysis |
6.2.2 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume, By Early-Stage Treatment, 2021 - 2031F |
6.2.3 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume, By Moderate to Severe Cases, 2021 - 2031F |
6.2.4 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume, By Pain Management, 2021 - 2031F |
6.2.5 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume, By Inflammation Control, 2021 - 2031F |
6.3 Israel Ankylosing Spondylitis Treatment Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.4 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.5 Israel Ankylosing Spondylitis Treatment Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Israel Ankylosing Spondylitis Treatment Market Import-Export Trade Statistics |
7.1 Israel Ankylosing Spondylitis Treatment Market Export to Major Countries |
7.2 Israel Ankylosing Spondylitis Treatment Market Imports from Major Countries |
8 Israel Ankylosing Spondylitis Treatment Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis of ankylosing spondylitis |
8.2 Percentage of ankylosing spondylitis patients receiving treatment in Israel |
8.3 Number of clinical trials for new ankylosing spondylitis treatments conducted in Israel |
8.4 Patient adherence rates to prescribed treatment regimens |
8.5 Number of healthcare facilities offering specialized ankylosing spondylitis care in Israel |
9 Israel Ankylosing Spondylitis Treatment Market - Opportunity Assessment |
9.1 Israel Ankylosing Spondylitis Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Israel Ankylosing Spondylitis Treatment Market Opportunity Assessment, By Treatment Stage, 2021 & 2031F |
9.3 Israel Ankylosing Spondylitis Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Ankylosing Spondylitis Treatment Market - Competitive Landscape |
10.1 Israel Ankylosing Spondylitis Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Ankylosing Spondylitis Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here